JHUCIR Profile Banner
JohnsHopkinsCIR Profile
JohnsHopkinsCIR

@JHUCIR

Followers
525
Following
3K
Media
194
Statuses
1K

@JohnsHopkins Vaccine Research Center. CIR facilitates the development of new #vaccines for infectious diseases of global importance. #VaccinesWork🔬

Baltimore, MD
Joined September 2017
Don't wanna be here? Send us removal request.
@JHUCIR
JohnsHopkinsCIR
1 month
Measles Update and ACIP News. CIR director Dr. Anna Durbin details the current outbreak and how recent changes to public health entities could affect vaccine policies. #vaccineswork #Measles #PublicHealth .
0
0
0
@JHUCIR
JohnsHopkinsCIR
2 months
RT @WHO: Congratulations! #Suriname 🇸🇷 is the first country in the Amazon region to be certified malaria-free by WHO. This milestone is a….
0
80
0
@grok
Grok
1 day
Join millions who have switched to Grok.
86
153
1K
@JHUCIR
JohnsHopkinsCIR
2 months
RT @gavi: There are two new COVID-19 variants that are rapidly spreading and competing for global dominance. Here are 8 things you need to….
Tweet card summary image
gavi.org
The NB.1.8.1 and XFG sub-variants are rapidly spreading and competing for global dominance.
0
19
0
@JHUCIR
JohnsHopkinsCIR
3 months
Webinar: Controlled human infection models in vaccine development: what’s new in 2025?. Thursday May 29th 2025.11:00 EDT. CIR Director, Dr. Anna Durbin, joins the panel of experts to discuss the opportunities and challenges of CHIMs in 2025 and beyond.
Tweet media one
0
0
1
@JHUCIR
JohnsHopkinsCIR
4 months
RT @DefeatDD: 🧼🫧It's World #HandHygiene Day! Handwashing with soap can reduce diarrheal diseases by 30%—and hand hygiene saves millions of….
0
2
0
@JHUCIR
JohnsHopkinsCIR
4 months
RT @dr_andrealove: FDA-approved vaccines had randomized, placebo-controlled trials. Polio?.Measles, mumps, rubella?.Haemophilus influenzae….
0
611
0
@JHUCIR
JohnsHopkinsCIR
5 months
CIR faculty member Brittany Feijoo is a next generation leader in the fight against diarrheal diseases! Read a recent Q&A with her in Defeat DD. #PublicHealth #publichealthheroes 🏅✨🌟👍.
Tweet card summary image
defeatdd.org
We talked to Brittany Feijoo, a research associate at Johns Hopkins, about her career path and her research on diarrheal diseases in Kenya.
0
0
0
@JHUCIR
JohnsHopkinsCIR
7 months
Dr. Kawsar Talaat talks about the Vaccine Adverse Event Reporting System (VAERS) in this recent local news segment. #vaccines .
0
0
0
@JHUCIR
JohnsHopkinsCIR
9 months
RT @CDCgov: Our nation’s ability to live healthier, longer lives rests on our commitment to supporting public health initiatives and the in….
0
128
0
@JHUCIR
JohnsHopkinsCIR
9 months
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
0
@JHUCIR
JohnsHopkinsCIR
9 months
CIR faculty and staff came together for the first All Hands on Deck meeting. It was the first all-teams gathering since moving to our new home in the Rangos Building and was the perfect opportunity to catch up and share face-to-face updates with CIR family.🌟🫶 #togetherness
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
3
@JHUCIR
JohnsHopkinsCIR
11 months
CIR Director Dr. Anna Durbin:.The goal was to give the drug, which would then prevent dengue from replicating after infection, so that if you were exposed to dengue, you wouldn't get sick. #dengue #vaccine.
0
0
0
@JHUCIR
JohnsHopkinsCIR
11 months
Dr. Ruth Karron: "Every country should ultimately have the opportunity to select the type of intervention, maternal immunization, or long-acting monoclonal antibody, that best fits the needs of its population or health system." Watch now.#RSV via @YouTube.
0
0
0